Bodal Chemicals Limited Fundamental Analysis (NSE: BODALCHEM.NS)
Bodal Chemicals Limited Fundamental Analysis (NSE: BODALCHEM.NS)
Bodal Chemicals Limited (NSE: BODALCHEM.NS) shows weak financial fundamentals with a PE ratio of 35.09, profit margin of 3.03%, and ROE of 6.03%. The company generates $22.7B in annual revenue with strong year-over-year growth of 25.12%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 55.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze BODALCHEM.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakBODALCHEM.NS struggles to generate sufficient returns from assets.
Valuation Score
ModerateBODALCHEM.NS shows balanced valuation metrics.
Growth Score
ModerateBODALCHEM.NS shows steady but slowing expansion.
Financial Health Score
ModerateBODALCHEM.NS shows balanced financial health with some risks.
Profitability Score
WeakBODALCHEM.NS struggles to sustain strong margins.
Key Financial Metrics
Is BODALCHEM.NS Expensive or Cheap?
P/E Ratio
BODALCHEM.NS trades at 35.09 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BODALCHEM.NS's PEG of 0.26 indicates potential undervaluation.
Price to Book
The market values Bodal Chemicals Limited at 2.08 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.61 times EBITDA. This signals the market has high growth expectations.
How Well Does BODALCHEM.NS Make Money?
Net Profit Margin
For every $100 in sales, Bodal Chemicals Limited keeps $3.03 as profit after all expenses.
Operating Margin
Core operations generate 5.29 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.03 in profit for every $100 of shareholder equity.
ROA
Bodal Chemicals Limited generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bodal Chemicals Limited generates limited operating cash flow of $778.82M, signaling weaker underlying cash strength.
Free Cash Flow
Bodal Chemicals Limited generates weak or negative free cash flow of $587.21M, restricting financial flexibility.
FCF Per Share
Each share generates $4.66 in free cash annually.
FCF Yield
BODALCHEM.NS converts 2.44% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
35.09
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.26
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.08
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.06
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How BODALCHEM.NS Stacks Against Its Sector Peers
| Metric | BODALCHEM.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 35.09 | 26.20 | Worse (Expensive) |
| ROE | 6.03% | 1241.00% | Weak |
| Net Margin | 3.03% | 441.00% | Weak |
| Debt/Equity | 0.00 | 0.72 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 3.12 | Weak Liquidity |
| ROA | 0.00% | 2616.00% | Weak |
BODALCHEM.NS outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bodal Chemicals Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
24.34%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
-79.40%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
286.88%
Industry Style: Cyclical, Commodity, Value
High Growth